Tenmile
Evergreen $250M health-tech fund backed by Andrew and Nicola Forrest's Tattarang, built to connect Australian life science breakthroughs to global markets without closed-end fund constraints.
Offices
Investment Focus
HealthtechBiotechMedtechMental HealthCNSCell TherapyGene TherapyWomen's HealthOncologyImmunologyAntimicrobialsAMRDrug Discovery Tools
Founded
2022
Investment Themes
Impact-Focused
Bio/Health-Focused
Tattarang
Female-Owned
Thesis-Driven
You're viewing 1 investor
Go from one investor to the complete database.
Every investor · Stages · Sectors · Locations · CSV + Excel
Get the Complete Investor Database →Similar Investors
Atlas Venture
Seed · Series A · Series B
Cambridge
Frazier Life Sciences
Seed · Series A · Series B
Palo Alto · Seattle +2
Awareness Capital
Series A · Series B
Westport
Forty51 Ventures
Seed · Series A
Basel
K2 Bio Partners
Pre-Seed · Seed · Series A
Beijing · Shanghai +1
Hatteras Venture Partners
Seed · Series A · Series B
Durham
Related Investor Lists
Still just 1 investor
Get the complete database — not just this profile.
Every investor · Stages · Sectors · Locations · CSV + Excel
Get the Complete Investor Database →